With over a decade of experience in the healthcare industry, Erik brings extensive expertise in managing Pharmaceutical and large NIH/NCI Phase I-III sponsored clinical trials across diverse disease groups, including Neurology, Oncology, Cardiology, Pulmonary critical care, Pediatrics, and Physical and Occupational therapies.
His educational background includes a Master of Business Administration with a focus on Healthcare administration/management and a Bachelor of Science in Health, Society, and Policy.